![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. An Essential Role for DYF-11/MIP-T3 in Assembling Functional Intraflagellar Transport Complexes 1Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada 2McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America 3Karolinska Institute, Department of Biosciences and Nutrition, Södertörn University College, School of Life Sciences, Huddinge, Sweden 4Samuel Lunenfeld Research Institute, Mount Sinai Hospital and Department of Microbiology and Medical Genetics, University of Toronto, Ontario, Canada 5Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada Susan Dutcher, Editor Washington University, United States of America #Contributed equally. * E-mail: leroux/at/sfu.ca ¶These authors also contributed equally to this work. Conceived and designed the experiments: CL PI CCL EE NZ CM ED PS NK ML. Performed the experiments: CL PI CCL EE NZ CM ED NB MH. Analyzed the data: CL PI CCL EE NZ NB MH PS NK ML. Contributed reagents/materials/analysis tools: CL PI EE EH MZ PS NK ML. Wrote the paper: PI NK ML. Received August 30, 2007; Accepted February 28, 2008. This article has been cited by other articles in PMC.Abstract MIP-T3 is a human protein found previously to associate with microtubules and the kinesin-interacting neuronal protein DISC1 (Disrupted-in-Schizophrenia 1), but whose cellular function(s) remains unknown. Here we demonstrate that the C. elegans MIP-T3 ortholog DYF-11 is an intraflagellar transport (IFT) protein that plays a critical role in assembling functional kinesin motor-IFT particle complexes. We have cloned a loss of function dyf-11 mutant in which several key components of the IFT machinery, including Kinesin-II, as well as IFT subcomplex A and B proteins, fail to enter ciliary axonemes and/or mislocalize, resulting in compromised ciliary structures and sensory functions, and abnormal lipid accumulation. Analyses in different mutant backgrounds further suggest that DYF-11 functions as a novel component of IFT subcomplex B. Consistent with an evolutionarily conserved cilia-associated role, mammalian MIP-T3 localizes to basal bodies and cilia, and zebrafish mipt3 functions synergistically with the Bardet-Biedl syndrome protein Bbs4 to ensure proper gastrulation, a key cilium- and basal body-dependent developmental process. Our findings therefore implicate MIP-T3 in a previously unknown but critical role in cilium biogenesis and further highlight the emerging role of this organelle in vertebrate development. Author Summary The transport of protein complexes and associated cargo along microtubule tracks represents an essential eukaryotic process responsible for a multitude of cellular functions, including cell division, vesicle movement to membranes, and trafficking along dendrites, axons, and cilia. The latter organelles are hair-like cellular appendages implicated in cell and fluid motility, sensing and transducing information from their environment, and development. Their biogenesis and maintenance depends on a kinesin- and dynein-mediated motility process termed intraflagellar transport (IFT). In addition to comprising these specialized molecular motors, the IFT machinery consists of large multisubunit complexes whose exact composition and organization has not been fully defined. Here we identify a protein, DYF-11/MIP-T3, that is conserved in all ciliated organisms and is associated with IFT in C. elegans. Disruption of C. elegans DYF-11 results in structurally compromised cilia, likely as a result of IFT motor and subunit misassembly. Animals lacking DYF-11 display chemosensory anomalies, consistent with a role for the protein in cilia-associated sensory processes. In zebrafish, MIP-T3 is essential for gastrulation movements during development, similar to that observed for other ciliary components, including Bardet-Biedl syndrome proteins. In conclusion, we have identified a novel IFT machinery component that is also essential for development in vertebrates. Introduction Cilia are slender subcellular structures that protrude from the surfaces of most eukaryotic cell types, where they carry out functions associated with sensation and/or motility. Motile cilia are used for the locomotion of spermatozoa or organisms such as the unicellular green alga Chlamydomonas reinhardtii, as well as for generating fluid flow, as is the case in respiratory airways [1]. Non-motile (primary) cilia are nearly ubiquitous in multicellular organisms, and perform a wide range of sensory functions, including chemosensation/olfaction, photoreception, and mechanosensation [1]–[5]. Primary cilia are also associated with several signaling processes critical for development, including Hedgehog signaling, PDGFRαα signaling, as well as canonical and non-canonical (planar cell polarity) Wnt signaling pathways [6]–[12]. Hence, defects in ciliary structure or function affect nearly every organ in humans, and are associated with several pleiotropic genetic disorders. For example, Bardet-Biedl syndrome (BBS), Alström syndrome, Meckel syndrome, Senior-Løken syndrome, Joubert syndrome, and several cystic kidney diseases are all believed to involve dysfunction of primary cilia and/or basal bodies, the modified centriolar structures that nucleate ciliary axonemes [13]–[20]. Cilia are organelles that require several hundred proteins to support their motility and/or sensory and signaling functions [21],[22]. Of particular relevance to the present study, cilia possess a specialized microtubule-based transport system, termed intraflagellar transport (IFT), which shuttles IFT complexes bi-directionally along the axoneme and supports the formation and maintenance of the organelles [23]–[25]. The IFT particles, first observed in Chlamydomonas [26] consist of anterograde Kinesin-2 motor(s) that move cargo into the cilia and a retrograde dynein motor involved in recycling components back to the base (basal body). The molecular motors are associated with two biochemically-separable multisubunit assemblies termed IFT particle subcomplexes A and B [27]–[29]. In Chlamydomonas, IFT subcomplexes A and B consist of at least 6 and 11 subunits, respectively. In recent years, the nematode Caenorhabditis elegans has emerged as a powerful model organism for the study of cilia and ciliogenesis. The cilia of C. elegans are non-motile and restricted to a subset of sensory neuronal cells principally localized in the head and tail of the animal [30]. While structurally similar to the canonical flagella of Chlamydomonas, C. elegans cilia emanate from a potentially more degenerate basal body (termed transition zone) and exhibit, following the doublet microtubule-containing ciliary middle segment, a pronounced extension of singlet axonemal microtubules in their distal segments [30]. Despite these differences, most, if not all, of the core IFT components identified in Chlamydomonas appear to be conserved in nematodes [31]. Additionally, several other proteins associated with and necessary for the function of the IFT machinery and cilium formation have been discovered in C. elegans, namely DYF-1 [32] DYF-2 [33], DYF-3 [34], DYF-13 [35], and IFTA-1 [36]. Like known IFT particle subcomplex A/B components, orthologs of these C. elegans proteins are enriched within the membrane-plus-matrix fraction of the recently identified Chlamydomonas flagellar proteome [37], supporting the notion that they represent conserved IFT components. In addition, research in the worm has shown that Bardet-Biedl Syndrome (BBS) proteins are themselves associated with IFT and are required to maintain the integrity of the IFT particle during transport along the cilium [4],[32]. The discovery of novel C. elegans IFT proteins suggests that the IFT machinery is more complex than suspected originally from biochemical fractionation studies, raising the possibility that additional components critical for IFT have yet to be identified. On the basis of several bioinformatic, genomic and proteomic studies, we recently surmised [21] that the microtubule-associated MIP-T3/TRAF3IP1 protein likely represents a previously unknown but conserved ciliary protein. Here, we show that the C. elegans dyf-11 mutant harbors a loss of function mutation in the gene encoding the MIP-T3 ortholog. We demonstrate that the dyf-11 gene product, DYF-11, is a novel IFT-associated protein required for the proper assembly and function of the IFT machinery, as well as the sensory abilities of cilia. Consistent with these findings, mammalian MIP-T3 localizes to the basal body in a pre-ciliated cell and to the ciliary axoneme in ciliated cells. Furthermore, suppressing the Danio rerio (zebrafish) mipt3 gene leads to a range of developmental defects recently associated with cilia function, most prominently cell movement anomalies during gastrulation, a process under the control of the non-canonical Wnt signaling pathway [12]. Our findings therefore demonstrate new roles for the evolutionarily conserved DYF-11/MIP-T3 protein in building and maintaining functional cilia, and in developmental signaling pathways. Results/Discussion The C. elegans MIP-T3 Gene Ortholog C02H7.1 Is Disrupted in dyf-11 Mutants Several lines of evidence support the notion that MIP-T3 orthologs have a ciliary function [21]. First, MIP-T3 is found exclusively in ciliated organisms [38],[39]. Second, its expression in C. elegans and Drosophila is restricted to ciliated cells and under the control of an X box motif, which regulates genes required for ciliogenesis [35],[38],[40],[41]. Similarly, Chlamydomonas MIP-T3 (C_140070) is upregulated during flagellar regeneration, and proteomic analyses uncovered MIP-T3 in the Chlamydomonas flagellar proteome [37],[42]. MIP-T3 proteins range in size from 484 to 625 amino acids and have no recognizable domains except for a predicted coiled-coil region near the C-terminus (Figure 1A
To test the hypothesis that MIP-T3 encodes a ciliary protein and to analyze its in vivo function, we sought to obtain a strain with a disruption in the C. elegans C02H7.1 open reading frame that encodes MIP-T3 (Figure S1). We noticed that a previously identified mutant, dyf-11(mn392), whose compromised fluorescent dye uptake is suggestive of cilia dysfunction [43], maps within a genetic interval that contains C02H7.1. Sequencing of C02H7.1 in the dyf-11(mn392) mutant strain revealed a nonsense mutation predicted to give rise to a null allele (Figure 1B DYF-11 Is Required for the Formation of Structurally Intact and Functional Cilia To determine if the dye-filling anomaly observed in the dyf-11 strain stems from structural defects in cilia that are normally exposed to the environment, we expressed GFP in the ASER amphid (head) or two PHA/B phasmid (tail) neurons using reporter constructs driven by the gcy-5 or srb-6 gene promoters, respectively; in those neurons, GFP diffuses freely to highlight the entire cell, including the cell body, axon, dendrite, transition zone/basal body and cilium, so as to permit cilium length measurements [44]. Although no morphological defects with the dendritic processes or transition zone positioning were observed, the cilia of dyf-11 mutants were truncated substantially (2.4±0.3 µm and 2.6±0.4 µm for amphids and phasmids, respectively) compared to those of wild-type animals (both 5.7±0.4 µm) (Figure 2A
We next used established assays [30], [45]–[47] to ask whether dyf-11 animals exhibit phenotypes consistent with cilia dysfunction, including anomalies in chemotaxis, avoidance of high osmolarity, ability to form stress-resistant dauer larvae, and lifespan. We first compared the ability of wild-type and dyf-11 mutant animals to detect a volatile odorant, isoamyl-alcohol. Although the dyf-11 mutants are not impaired in their movement (data not shown), they show a pronounced inability to chemotax towards the attractant, indicative of an abnormal Chemotaxis (Che) phenotype (Figure 2B We then tested for the ability of dyf-11 mutants to enter the alternative dauer lifestage at two different temperatures (20/25°C). While wild-type larvae become dauers at these temperatures upon starvation, mutants with defects in IFT (e.g., osm-5) or the cilium-dependent insulin signaling pathway (e.g., daf-16 and daf-2) are either dauer formation-defective (Daf-d) or constitutively form dauer larvae (Daf-c) [47] (Figure 2D Intriguingly, dyf-11 mutants also show, compared to the wild-type and rescue strains, a pronounced increase in Nile Red staining within intestinal cells, indicative of an increased lipid accumulation phenotype (Figure 2F Altogether, our cilium length measurements and sensory behavioral analyses (Che, Osm and Daf) demonstrate that the dyf-11 mutant strain possesses prominent structural and functional ciliary defects, confirming our hypothesis that MIP-T3 plays a role in ciliogenesis and cilia function. The role(s) of DYF-11/MIP-T3 in cilia formation and function appear to be highly specific, as we have not noted any gross morphological, developmental or locomotory defects in dyf-11 mutant animals. DYF-11/MIP-T3 is a Novel Intraflagellar Transport (IFT) Protein To directly observe whether the C. elegans DYF-11 protein associates with ciliary structures (transition zones/basal bodies and/or cilia), we generated transgenic lines bearing a translational fusion construct of the complete dyf-11 gene (with its endogenous promoter) and GFP. Fluorescence microscopy observation of the lines revealed that dyf-11::gfp is expressed specifically in ciliated (e.g., amphid and phasmid) sensory neurons (data not shown), consistent with expression patterns obtained using transcriptional GFP-fusion constructs obtained in two large-scale studies [35],[52]. Importantly, the DYF-11::GFP protein was found to be highly enriched at transition zones and within ciliary axonemes (Figure 3A
Time-lapse microscopy in C. elegans revealed that DYF-11::GFP localization is not static; the GFP-tagged protein moves bi-directionally along the length of amphid and phasmid ciliary axonemes (Figure 3A Interestingly, DYF-11::GFP can be observed in several additional dendritic extensions that are not typically seen with established GFP-tagged IFT protein markers (see hollow arrowheads in Figure 3A DYF-11 Is Transported in the Cilium in a Manner Similar to IFT Particle Subcomplex B The molecular architecture of the motor-IFT machinery has been studied in some detail, using mainly Chlamydomonas and C. elegans as model systems [25], [28], [54], [56]–[60]. In C. elegans, the motor-IFT machinery consists of at least 32 components organized into three main modules [58]: a motor module with two kinesin-2-like anterograde motors for anterograde transport (the more canonical heterotrimeric Kinesin-II, and homodimeric OSM-3) and a dynein motor for retrograde transport; another module containing two IFT particle multisubunit subcomplexes (A and B) that are separable genetically and biochemically [27]–[29],[32],[54],[58]; finally, a BBS protein complex/module that mediates the association between Kinesin-II/subcomplex A and OSM-3/subcomplex B [4],[32],[61]. Having identified DYF-11 as a novel IFT protein, we sought to characterize its spatial relationship (i.e., localization in one of the aforementioned modules) and function with respect to other components of the IFT machinery. To test whether DYF-11 may be a component of either the Kinesin-II or OSM-3 anterograde motor modules, similar to the association of DYF-1 with OSM-3 [32], we queried whether GFP-tagged DYF-11 enters the ciliary axonemes of mutants lacking either motor (compared with Figure 4A We therefore analyzed the behavior of DYF-11::GFP in the three available bbs mutants (bbs-1, bbs-7/osm-12 and bbs-8). In all bbs mutants, DYF-11::GFP was distributed throughout the middle segment and the residual distal segment (Figures 4D–F When combined with our finding that dyf-11 mutant cilia are truncated to the same extent as those mutants with abrogated IFT subcomplex B components such as OSM-5/IFT88, OSM-6/IFT52, and CHE-13/IFT55-57 (Figure 2A
DYF-11 Is Required for the Integrity of the Motor-IFT Machinery To provide additional insight into the function of DYF-11 with regards to the motor-IFT machinery and cilia formation, we analyzed by microscopy the behavior of several GFP-tagged IFT-associated components in the dyf-11 mutant strain. In addition to the IFT subcomplex B protein OSM-5 (see above), we tested a Kinesin-II component (the Kinesin-Associated Protein 1, KAP-1), homodimeric kinesin OSM-3, a component of IFT-dynein (the light-intermediate chain XBX-1), an IFT particle subcomplex A protein (CHE-11/IFT140), and a BBS protein (BBS-7). In wild-type animals, these proteins always localize prominently at transition zones/basal bodies and clearly undergo bidirectional transport along ciliary axonemes (Figures 5A–F Vertebrate MIP-T3 Is Likely Necessary for Morphogenetic Signal Transduction To provide in vivo evidence that DYF-11/MIP-T3 plays a ciliary role in vertebrates, we turned to Danio rerio (zebrafish), whose ortholog (LOC393572) exhibits 51% amino acid identity to its human counterpart (Figure 1A = 100–150 embryos per injection) and with high specificity, since co-injection of a mipt3 MO with a mipt3 capped mRNA rescued >95% of the affected embryos for all phenotypes scored (n = 120; Figures 6A–E
To confirm that the observed defects were a result of defective gastrulation movements, we labeled a single blastomere in MO injected embryos at the 16-cell stage and followed the labeled cell populations through epiboly. As compared to control and WT rescue embryos (Figure 6E Importantly, MO-based knockdown of both mipt3 and bbs4, which encodes a BBS protein that localizes to centriolar satellites (proximal to basal body) and is necessary for gastrulation movements [63], led to morphogenetic phenotypes that were more severe than with the knockdown of either gene alone. Injection of subeffective doses of mipt3 or bbs4 MOs yielded observable phenotypes in <20% of embryos (n = 113 and 127, respectively) (Figures 6A, 6BConcluding Remarks Human MIP-T3 (Microtubule-interacting protein associated with TRAF3), also termed TRAF3IP1 (TNF Receptor-Associated Factor 3 Interacting Protein 1), is a poorly-characterized protein previously implicated in TRAF3 function and shown to bind microtubules [66]. More recently, Morris et al [67] found that MIP-T3 interacts with the DISC1 (Disrupted-in-schizophrenia 1) protein and is required for its localization to microtubules/centrosomes. Yet, given that MIP-T3 protein orthologs are present in organisms lacking both TRAF3 and DISC1, including B. dendrobatidis, Chlamydomonas and C. elegans (Figure 1A Another potentially pertinent discovery by Taya et al [69] is that the MIP-T3-interacting protein DISC1 regulates the Kinesin-1-dependent transport of a protein complex composed of NUDEL/LIS1/14-3-3ε. Consistent with a probable role in transport and neurogenesis, overexpression of a dominant-negative variant of DISC1 results in defective (shortened) neurite outgrowths [70]. Hence, one of the apparent functions of DISC1 as a cohesion factor for a multisubunit protein complex (NUDEL/LIS1/14-3-3ε) has interesting parallels to that of its interacting partner MIP-T3, which we show may function as a subunit of the IFT subcomplex B that possibly links, either directly or indirectly, a ciliary kinesin to the multiprotein IFT subcomplexes A/B (Figure 4 Several genome- and proteome-wide studies are in accord with our finding that MIP-T3 plays a critical role in IFT. The Chlamydomonas flagellar proteome uncovered by Pazour et al [37] identified the MIP-T3 ortholog (FAP116) as an abundant protein present specifically in the membrane-plus-matrix but not the axonemal fraction of cilia, precisely like other IFT proteins. Chlamydomonas MIP-T3 is upregulated >3.0 fold during reflagellation [39],[42], again similar to other IFT proteins and consistent with a ciliogenic role. Finally, just as in C. elegans, the Drosophila MIP-T3 ortholog (CG3259) is expressed exclusively in ciliated sensory neurons [38]. Our morpholino knockdown studies in the vertebrate Danio rerio (Figure 6 Materials and Methods Strain Construction and Maintenance All C. elegans strains were maintained at 20°C, and standard genetic crosses were employed to introduce GFP reporter constructs (transcriptional or translational) into wild-type (N2) or mutant animals. PCR or dye-filling assays were used to follow genotypes, as described [36]. The following mutant strains were used in this study: bbs-1(ok1111), bbs-7/osm-12(n1606), bbs-8(nx77), che-3(e1124) che-11(e1810), che-13(e1805), daf-2(e1370), daf-16(mu86), dyf-11(mn392) klp-11(tm324), osm-3(p802), osm-5(p813), and osm-6(p811). Construction of Strains Harboring a Translational DYF-11::GFP Construct A translational DYF-11::GFP fusion construct was made by fusion PCR as described [53]. The entire genomic coding region of dyf-11 (C02H7.1), along with 528 bp of promoter sequence 5′ of the start codon, was fused upstream of, and in frame with, the GFP coding sequence. Aside from DYF-11::GFP, the following strains were used: dpy-5(e907); Ex[gcy-5p::gfp+dpy-5(+)] dpy-5(e907); nxEx[osm-12::gfp+dpy-5(+)], N2; myEx10[che-11::gfp+rol-6(su1006)]; N2; Ex[kap-1::gfp+rol-6(su1006)], N2; ejEx1[osm-3::gfp+rol-6(su1006)], N2; yhEx2[osm-5::gfp+rol-6(su1006)], N2; Ex[srb-6p::gfp+rol-6(su1006)] and N2; nxEx[xbx-1::gfp+rol-6(su1006)]. Localization of MIP-T3 in Mammalian Cells A tagged expression construct for MIP-T3 was generated by LR clonase II (Invitrogen) mediated recombination between the pENTR 221-MIP-T3 (Ultimate ORF clone IOH28851; Invitrogen) and pcDNA6.2/nLumio-DEST (Invitrogen), placing the human MIP-T3 ORF under control of a CMV promoter with an N-terminal V5 epitope tag (pcDNA6.2/nLumio-MIP-T3). IMCD3 cells were plated on glass coverslips and transfected with the pcDNA6.2/nLumio-MIP-T3 vector when cells reached 60% confluency by using FuGENE6 (Roche) transfection reagent. Twenty-four hours post-transfection, cells were fixed in methanol and stained using mouse anti-V5 (1 200, Invitrogen), mouse anti- γ-tubulin or mouse anti- acetylated-tubulin (both 1 1000, Sigma), and secondary detection carried out with goat anti-mouse IgG antibody conjugated to Alexa 488 dye, and goat anti-mouse IgG antibody conjugated to Alexa 594 (both 1 1000, Invitrogen). Cells were visualized by fluorescence microscopy.Cloning of dyf-11 (C02H7.1) The C. elegans MIP-T3 gene homolog, C02H7.1, is physically situated close to the interval defined for the dyf-11(mn392) mutant allele (X: −18.27±0.244 cM) [43], suggesting that the genetic lesion lies within this gene. We sequenced the C02H7.1 coding region in the dyf-11 mutant and uncovered a nonsense mutation (TCA→TGA) in the third exon at nt 419 of the coding region. Primer sets used to detect the mutation were: OPS0320 TGGTCGCAATTTGACCACC and OPS0322 TGATCATTCTCGGGCTCTC (fragment 1); OPS0321 GACGATCATGAGATTTCTG and OPS0323 CAACATATTGGTGCAACTTC (fragment 2). A second putative dyf-11 allele, ad1303, had no sequence alterations in exons and complemented the dyf-11(mn392) mutation, suggesting that it represents a different gene. C. elegans Phenotypic Analyses Dye-filling assays using the fluorescent dye DiI were performed as described [53]. Chemotaxis assays were carried out for 1 hour essentially as described [46], using isoamyl-alcohol as a chemoattractant. A chemotaxis index was calculated as the number of worms in attractant zone minus worms in control zone, divided by the total number of worms. Osmo-avoidance assays were performed as described [46]. Briefly, ~5 worms (for each of at least 20 assays) were placed inside a small ring of 8 M glycerol, and animals found within or beyond the ring after 10 minutes were counted as non-avoiders. An osmo-avoidance index was calculated: (total avoiders–non-avoiders)/total worms. Lifespan assays were based on the protocol of Apfeld and Kenyon [49]. Animals were grown for at least one generation at 20°C before eggs were collected. At the L4 molt, worms were transferred to NGM plates containing 16 µM fluorodeoxyuridine (FUDR) to prevent progeny growth and kept at 20°C throughout the assay. 100 worms were picked for each strain, at 10 worms/plate. Worms were scored every 1–2 days for viability; those no longer responding to prodding with platinum wire were considered dead, and those that exploded or crawled off the plate were censored. To test for entry into and exit from the dauer stage, we employed an existing strategy [73]. 10 adult worms were allowed to lay eggs on plates with food at 20°C for 4 hours. Adults were then removed and eggs counted. Eggs were allowed to develop for 4 days at 20°C or 3 days at 25°C, after which they were scored as either Daf-c or Daf-d as follows. To identify Daf-c worms, plates were flooded with 1% SDS, where only dauer larvae remained as live thrashing animals after 15 minutes. To identify Daf-d worms, animals were allowed to grow 4 days following complete consumption of food, after which they were exposed to and unable to survive the 1% SDS treatment. daf-16 (mu86) and daf-2 (e1370) were used as Daf-d and Daf-c controls, respectively. All dauer/lifespan assays were carried out in duplicate or triplicate. Nile Red staining was performed as previously described [50]. Briefly, Nile Red powder (Molecular Probes) was dissolved in acetone as a 1mg/ml stock solution and kept at room temperature. The stock solution was diluted in 1x PBS to 1 ug/ml and 0.5 ml of diluted solution was applied to NGM plates seeded with E.coli OP50. Plates were allowed to dry for 24 hours. Staged eggs were allowed to develop on Nile Red plates at 20°C. Worms were transferred every 2 days to fresh Nile Red plates and were analyzed two days post-L4 by fluorescence microscopy. Images were captured and processed under identical settings using OpenLab software (Improvision, Inc). Nile Red fluorescence intensity was calculated as the mean pixel intensity after background subtraction. Analysis of Sensory Neuron Structure and Cilia Length Measurements ASER amphid and PHA/PHB phasmid sensory neuron structures were visualized by expressing the cell-specific transcriptional reporters, gcy-5p::gfp and srb-6p::gfp [36], respectively. In these neurons, the GFP diffuses freely throughout the neuron to mark cell bodies, axons, dendrites, transition zones and cilia. Cilium length was measured from the distal end of the transition zone (visible as a ‘bulge’ of fluorescence) to the distal tip of the cilium. Visualization of IFT and Rate Measurements by Time-Lapse Microscopy Transgenic animals expressing GFP-tagged proteins were mounted on agarose pads and immobilized with 20 mM levamisole. Amphid or phasmid cilia were examined with a 100X, 1.35 NA objective and an ORCA AG CCD camera mounted on an Zeiss Axioskop 2 mot plus microscope. Images and movies were obtained in Openlab version 5.02 beta (Improvision). Kymographs were generated using the MultipleKymograph ImageJ plug-in. Rates from middle and distal segments were obtained essentially as described in Snow et al [54]. Images for intraflagellar transport were collected using a Zeiss Axiovert 200 equipped with a Hamamatsu Orca AG CCD camera, spinning disk confocal head, Zeiss Plan-neofluar 63X, 1.3 NA, water-immersion objective and a 1.5X magnification lens Improvision Piezo Focus Drive. Images for MX488 bbs-7(n1606); Ex[dyf-11::GFP+dpy-1(+)] and MX486 N2; Is[dyf-11::GFP+dpy-1(+)] were collected at 7.5 frames/sec and 4.24 frames/sec respectively. Animals were first anaesthetized with 10 mM levamisole, mounted on agar pads and photobleached for 300–1900 ms before images were collected for 2 minutes. The FRAP module is a Photonic Instruments MOSAIC Digital Diaphragm System with a 488 nm 300 mW laser line. Images were collected using Volocity. Zebrafish Morpholino Knockdown Studies We obtained a translational blocking mipt3 morpholino (MO) from Gene Tools Inc (5′- ACCGATTCGTTCATGGCATCAAACC-3′). The MO was diluted to the desired concentrations in deionized, sterile water and injected into 2-cell stage embryos as described [64]. To rescue the morphant phenotypes, we amplified the open reading frame of zebrafish mipt3 and cloned it into the pCS2+ vector, from which we transcribed RNA using the SP6 mMessage mMachine kit (Ambion). Phenotypes and imaging were performed as described [64]. In situ hybridization, monitoring of gastrulation movements, and measuring of embryo body gap angles were carried out using previously described methods [12]. Measurements of rhombomere width and rhombomere-somite distances were taken on flat-mounted embryos photographed at 10X magnification. Intraocular distance was taken as the measurement of the width of the pax2-expressing region, labeled by ribostaining, and was measured on flat-mounted images photographed at 10X. All experiments were performed blinded to the injection cocktail. Movie S1 Time-lapse microscopy (4 frames/second) of C. elegans DYF 11::GFP seen moving bi-directionally along amphid cilia, as with other IFT proteins. (0.56 MB MOV) Click here for additional data file.(550K, mov) Figure S1 Amino acid alignment of C. elegans DYF-11 (C02H7.1) with MIP T3 protein orthologs from C. reinhardtii and H. sapiens. Identical and similar residues are highlighted in black and gray, respectively. Note that the major difference in size between the human and C. elegans/Chlamydomonas proteins are due to two large insertions found in the human protein sequence. The number of residues is displayed at the ends of the sequences. Caenorhabditis elegans DYF-11/MIP-T3: C02H7.1; Homo sapiens MIP-T3: AAF76984; Chlamydomonas reinhardtii MIP-T3 accession number: C_140070. (1.59 MB EPS) Click here for additional data file.(1.5M, eps) Figure S2 Fluorescence images indicating the possible presence of DYF 11::GFP in the distal segments of AWC neuron cilia. Two of the highlighted extensions (hollow arrowheads) from the DYF-11::GFP protein overlap with the RFP protein that is most highly expressed in AWC cilia. Two ‘branches’ of the AWC cilium are shown with arrows, and the bundle of amphid channel cilia are pointed to. The schematic shows the ultrastructure of the AWC cilium, as visualised in Perkins et al. (1986). Images were acquired in the strain OE3657 dpy-5(e907) I; dyf-11(mn392) X; nxEx[C02H7.1::gfp; dpy-5 (+)]; ofEx457 [odr-3::rfp; elt-2::cherry]. (4.94 MB TIF) Click here for additional data file.(4.7M, tif) Figure S3 Gastrulation phenotypes in mipt3 morphant embryos. (A) Injection of a progressively increasing amount of a translation-blocking mipt3 morpholino (MO) gives rise to a spectrum of gastrulation phenotypes, including shortening of the embryonic axis, broadening and kinking of the notochord, lengthening of the somites and detachment of cells along the embryonic axis. The presence of two of these phenotypes is scored as “Class I”, whereas three or more phenotypes are categorized as “Class II”. (B) Body gap angle measurements for mipt3 and bbs4 morphants. The gap angle of mid-somitic embryos (nine somites +/− one somite) as defined by the angle formed by triangulating three points (tip of head, tip of tail, center of yolk; see also Gerdes et al., 2007) was calculated to capture the mean length of embryo populations (n = 50–70 embryos). On the y-axis, the angle is plotted (in degrees) while the x-axis shows the various injection cocktails. The phenotype is rescued efficiently by co-injection of capped mipt3 mRNA. Note the significantly shorter embryos in the mipt3+bbs4 double morphants. Data were calculated blind to injection cocktail; bars depict standard error.(9.82 MB TIF) Click here for additional data file.(9.3M, tif) Figure S4 Quantification of gastrulation movement defects during epiboly. The mean width of fluorescein-positive region was measured across each time-point assayed in nine embryos per category (control, mipt3 morphant, and mipt3 rescue). Asterisks indicate statistically significant differences (p<0.05) between morphants and controls or rescued embryos; the latter two were indistinguishable from each other. (0.47 MB TIF) Click here for additional data file.(458K, tif) Acknowledgments We thank Leon Avery and Joseph Dent for providing us with the ad1303 allele, and T. Stiernagle and the C. elegans Genetics Center for providing strains. We also thank Mathieu Bakhoum, Chrystal Inglis and Harald Hutter for assistance with the project. Footnotes The authors have declared that no competing interests exist. This work was supported by the March of Dimes (to MRL), NIH grants HD042601, DK072301 and DK075972 (to NK), F32 DK0799541 (to EED), as well as the Swedish Research Council (VR) and the Swedish Foundation for Strategic Research (SSF) (to PS). MRL holds Michael Smith Foundation for Health Research (MSFHR) and CIHR scholar awards. PNI holds MSFHR and NSERC post-graduate scholar awards, and MPH holds a MSFHR scholarship. References 1. Pazour GJ, Rosenbaum JL. Intraflagellar transport and cilia-dependent diseases. Trends Cell Biol. 2002;12:551–5. [PubMed] 2. Davenport JR, Yoder BK. An incredible decade for the primary cilium: a once forgotten organelle. Am J Renal Physiol. 2005;289:1159–69. 3. Takeuchi H, Kurahashi T. Mechanism of signal amplification in the olfactory sensory cilia. J Neurosci. 2005;25:11084–91. [PubMed] 4. Satir P, Christensen ST. Overview of structure and function of mammalian cilia. Annu Rev Physiol. 2007;69:377–400. [PubMed] 5. Yoder BK. Role of primary cilia in the pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2007;18:1381–8. [PubMed] 6. Christensen ST, Pedersen LB, Schneider L, Satir P. Sensory cilia and integration of signal transduction in human health and disease. Traffic. 2007;8:97–109. [PubMed] 7. Davis EE, Breukner M, Katsanis N. The emerging complexity of the vertebrate cilium: new functional roles for an ancient organelle. Dev Cell. 2006;11:9–19. [PubMed] 8. Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, et al. PDGFRαα signaling is regulated through the primary cilium in fibroblasts. Curr Biol. 2005;15:1861–6. [PubMed] 9. Singla V, Reiter JF. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science. 2006;313:629–33. [PubMed] 10. Germino GG. Linking cilia to Wnts. Nat Genet. 2005;37:455–7. [PubMed] 11. Haycraft CJ, Banizs B, Aydin-Son Y, Zhang Q, Michaud EJ, et al. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein Polaris for processing and function. PLoS Genet. 2005;1:e53. [PubMed] 12. Gerdes JM, Liu Y, Zaghoul NA, Leitch CC, Lawson SS, et al. Disruption of the basal body compromises proteasomal function and perturbs intracellular Wnt response. Nat Genet. 2007;39:1350–60. [PubMed] 13. Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskin BE, et al. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature. 2003;425:628–63. [PubMed] 14. Pazour GJ. Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease. J Am Soc Nephrol. 2004;15:2528–36. [PubMed] 15. Badano JL, Mitsuma N, Beales PL, Katsanis N. The Ciliopathies: An Emerging Class of Human Genetic Disorders. Ann Rev Genom Hum Genet. 2006a;22:125–48. 16. Blacque OE, Leroux MR. Bardet-Biedl syndrome: an emerging pathomechanism of intracellular transport. Cell Mol Life Sci. 2006;63:2145–61. [PubMed] 17. Hildebrandt F, Otto E. Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease. Nat Rev Genet. 2005;6:928–40. [PubMed] 18. Dawe HR, Smith UM, Cullinane AR, Gerrelli D, Cox P, et al. The Meckel-Gruber Syndrome proteins MKS1 and meckelin interact and are required for primary cilium formation. Hum Mol Genet. 2007;16:173–86. [PubMed] 19. Li G, Vega R, Nelms K, Gekakis N, Goodnow C, et al. A role for Alstrom syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet. 2007;3:e8. [PubMed] 20. Tobin JL, Beales PL. Bardet-Biedl syndrome: beyond the cilium. Pediatr Nephrol. 2007;22:926–36. [PubMed] 21. Inglis PN, Boroevich KA, Leroux MR. Piecing together a ciliome. Trends Genet. 2006;22:491–500. [PubMed] 22. Gherman A, Davis EE, Katsanis N. The ciliary proteome database: an integrated community resource for the genetic and functional dissection of cilia. Nat Genet. 2006;38:961–2. [PubMed] 23. Kozminski KG, Beech PL, Rosenbaum JL. The Chlamydomonas Kinesin-like protein FLA10 is involved in motility associated with the flagellar membrane. J Cell Biol. 1995;131:1517–21. [PubMed] 24. Rosenbaum JL, Witman GB. Intraflagellar transport. Nat Rev Mol Cell Biol. 2002;3:813–25. [PubMed] 25. Scholey JM. Intraflagellar transport. Ann Rev Cell Dev Biol. 2003;19:423–43. [PubMed] 26. Kozminski KG, Johnson KA, Forscher P, Rosenbaum JL. A motility in the eukaryotic flagellum unrelated to flagellar beating. PNAS. 1993;90:5519–23. [PubMed] 27. Piperno G, Mead K. Transport of a novel complex in the cytoplasmic matrix of Chlamydomonas flagella. PNAS. 1997;94:4457–62. [PubMed] 28. Cole DG. The intraflagellar transport machinery of Chlamydomonas reinhardtii. Traffic. 2003;4:435–442. [PubMed] 29. Cole DG, Diener DR, Himelblau AL, Beech PL, Fuster JC, et al. Chlamydomonas Kinesin-II-dependent intraflagellar transport (IFT): IFT particles contain proteins required for ciliary assembly in Caenorhabditis elegans sensory neurons. J Cell Biol. 1998;141:993–1008. [PubMed] 30. Perkins LA, Hedgecock EM, Thomson JN, Culotti JG. Mutant sensory cilia in the nematode Caenorhabditis elegans. Dev Biol. 1986;117:456–487. [PubMed] 31. Inglis PN, Ou G, Leroux MR, Scholey JM. 2007. The sensory cilia of Caenorhabditis elegans. WormBook, ed. The C. elegans Research Community, WormBook, oi/10.1895/wormbook.1.7.1, http://www.wormbook.org. 32. Ou G, Blacque OE, Snow JJ, Leroux MR, Scholey JM. Functional coordination of intraflagellar transport motors. Nature. 2005;436:583–587. [PubMed] 33. Efimenko E, Blacque OE, Ou G, Haycraft CJ, Yoder BK, et al. Caenorhabditis elegans DYF-2, an orthologue of human WDR19, is a component of the intraflagellar transport machinery in sensory cilia. Mol Biol Cell. 2006;17:4801–11. [PubMed] 34. Murayama T, Toh Y, Ohshima Y, Koga M. The dyf-3 gene encodes a novel protein required for sensory cilium formation in Caenorhabditis elegans. J Mol Biol. 2005;346:677–87. [PubMed] 35. Blacque OE, Perens EA, Boroevich KA, Inglis PN, Li C, et al. Functional genomics of the cilium, a sensory organelle. Curr Biol. 2005;15:935–41. [PubMed] 36. Blacque OE, Li C, Inglis PN, Esmail MA, Ou G, et al. The WD repeat-containing protein IFTA-1 is required for retrograde intraflagellar transport. Mol Biol Cell. 2006;17:5053–62. [PubMed] 37. Pazour GJ, Agrin N, Leszyk J, Witman GB. Proteomic analysis of a eukaryotic cilium. J Cell Biol. 2005;170:103–113. [PubMed] 38. Avidor-Reiss T, Maer AM, Koundakjian E, Polyanovsky A, Keil T, et al. Decoding cilia function: defining specialized genes required for compartmentalized cilia biogenesis. Cell. 2004;117:527–539. [PubMed] 39. Li JB, Gerdes JM, Haycraft CJ, Fan Y, Teslovich TM, et al. Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell. 2004;117:541–552. [PubMed] 40. Efimenko E, Bubb K, Mak HY, Holzman T, Leroux MR, et al. Analysis of xbx genes in C. elegans. Development. 2005;132:1923–1934. [PubMed] 41. Chen N, Mah A, Blacque OE, Chu J, Phgora K, et al. Identification of ciliary and ciliopathy genes in Caenorhabditis elegans through comparative genomics. Genome Biol. 2006;2006:R126. [PubMed] 42. Stolc V, Samanta MP, Tongprasit W, Marshall WF. Genome-wide transcriptional analysis of flagellar regeneration in Chlamydomonas reinhardtii identifies orthologs of ciliary disease genes. PNAS. 2005;102:3703–3707. [PubMed] 43. Starich TA, Herman RK, Kari CK, Yeh WH, Schackwitz WS, et al. Mutations affecting the chemosensory neurons of Caenorhabditis elegans. Genetics. 1995;139:171–88. [PubMed] 44. Swoboda P, Adler HT, Thomas JH. The RFX-type transcription factor DAF-19 regulates sensory neuron cilium formation in C. elegans. Mol Cell. 2000;5:411–421. [PubMed] 45. Bargmann CI. 2006. Chemosensation in C. elegans. WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.7.1, http://www.wormbook.org. 46. Hart A. 2006. Behavior. WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.7.1, http://www.wormbook.org. 47. Vowels JJ, Thomas JH. Genetic analysis of chemosensory control of dauer formation in Caenorhabditis elegans. Genetics. 1992;130:105–23. [PubMed] 48. Liu KS, Sternberg PW. Sensory regulation of male mating behavior in Caenorhabditis elegans. Neuron. 1995;14:79–89. [PubMed] 49. Apfeld J, Kenyon C. Regulation of lifespan by sensory perception in Caenorhabditis elegans. Nature. 1999;402:804–9. [PubMed] 50. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature. 2003;421:268–72. [PubMed] 51. Mak HY, Nelson LS, Basson M, Johnson CD, Ruvkun G. Polygenic control of Caenorhabditis elegans fat storage. Nat Genet. 2006;38:363–8. [PubMed] 52. Kunitomo H, Uesugi H, Kohara Y, Iino Y. Identification of ciliated sensory neuron-expressed genes in Caenorhabditis elegans using targeted pull-down of poly(A) tails. Genome Biol. 2005;6:R17. [PubMed] 53. Blacque OE, Reardon MJ, Li C, McCarthy J, Mahjoub MR, et al. Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev. 2004;18:1630–1642. [PubMed] 54. Snow JJ, Ou G, Gunnarson AL, Walker MR, Zhou HM, et al. Two anterograde intraflagellar transport motors cooperate to build sensory cilia on C. elegans neurons. Nat Cell Biol. 2004;6:1109–1113. [PubMed] 55. Burghoorn J, Dekkers MP, Rademakers S, de Jong T, Willemsen R, Jansen G. Mutation of the MAP kinase DYF-5 affects docking and undocking of Kinesin-2 motors and reduces their speed in the cilia of Caenorhabditis elegans. PNAS. 2007;24:7157–62. [PubMed] 56. Haycraft CJ, Schafer JC, Zhang Q, Taulman PD, Yoder BK. Identification of CHE-13, a novel intraflagellar transport protein required for cilia formation. Exp Cell Res. 2003;284:251–263. [PubMed] 57. Lucker BF, Behal RH, Qin H, Siron LC, Taggart WD, et al. Characterization of the intraflagellar transport complex B core: direct interaction of the IFT81 and IFT74/72 subunits. J Biol Chem. 2005;280:27688–27696. [PubMed] 58. Ou G, Koga M, Blacque OE, Murayama T, Ohshima Y, et al. Sensory Ciliogenesis in Caenorhabditis elegans: Assignment of IFT Components into Distinct Modules Based on Transport and Phenotypic Profiles. Mol Biol Cell. 2007;18:1554–1569. [PubMed] 59. Pedersen LB, Geimer S, Rosenbaum JL. Dissecting the molecular mechanisms of intraflagellar transport in Chlamydomonas. Curr Biol. 2006;16:450–459. [PubMed] 60. Pan X, Ou G, Civelekoglu-Scholey G, Blacque OE, Endres NF, et al. Mechanism of transport of IFT particles in C. elegans cilia by the concerted action of Kinesin-II and OSM-3 motors. J Cell Biol. 2006;174:1035–45. [PubMed] 61. Nachury MV, Loktev AV, Zhang Q, Westlake CJ, Peranen J, et al. A Core Complex of BBS Proteins Cooperates with the GTPase Rab8 to Promote Ciliary Membrane Biogenesis. Cell. 2007;129:1201–13. [PubMed] 62. Deane JA, Cole DG, Seeley ES, Diener DR, Rosenbaum JL. Localization of intraflagellar transport protein IFT52 identifies basal body transitional fibers as the docking site for IFT particles. Curr Biol. 2001;11:1586–90. [PubMed] 63. Ross AJ, May-Simera H, Eichers ER, Kai M, Hill J, et al. Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat Genet. 2005;37:1135–1140. [PubMed] 64. Badano JL, Leitch CC, Ansley SJ, May-Simera H, Lawson S, et al. Dissection of epistasis in oligogenic Bardet-Biedl syndrome. Nature. 2006b;439:326–30. [PubMed] 65. Simons M, Gloy J, Ganner A, Bullerkotte A, Bashkurov M, et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet. 2005;37:537–543. [PubMed] 66. Ling L, Goeddel DV. MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule network. J Biol Chem. 2000;275:23852–60. [PubMed] 67. Morris JA, Kandpal G, Ma L, Austin CP. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet. 2003;12:1591–608. [PubMed] 68. Bell LR, Stone S, Yochem J, Shaw JE, Herman RK. The molecular identities of the Caenorhabditis elegans intraflagellar transport genes dyf-6, daf-10 and osm-1. Genetics. 2006;173:1275–86. [PubMed] 69. Taya S, Shinoda T, Tsuboi D, Asaki J, Nagai K, et al. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through Kinesin-1. J Neurosci. 2007;27:15–26. [PubMed] 70. Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. PNAS. 2003;100:289–94. [PubMed] 71. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry. 2003;8:685–694. [PubMed] 72. Lee S, Walker CL, Karten B, Kuny SL, Tennese AA, et al. Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Hum Mol Genet. 2005;14:627–637. [PubMed] 73. Malone EA, Inoue T, Thomas JH. Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics. 1996;143:1193–205. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Trends Cell Biol. 2002 Dec; 12(12):551-5.
[Trends Cell Biol. 2002]J Am Soc Nephrol. 2007 May; 18(5):1381-8.
[J Am Soc Nephrol. 2007]Traffic. 2007 Feb; 8(2):97-109.
[Traffic. 2007]Nat Genet. 2007 Nov; 39(11):1350-60.
[Nat Genet. 2007]Nature. 2003 Oct 9; 425(6958):628-33.
[Nature. 2003]Trends Genet. 2006 Sep; 22(9):491-500.
[Trends Genet. 2006]Nat Genet. 2006 Sep; 38(9):961-2.
[Nat Genet. 2006]J Cell Biol. 1995 Dec; 131(6 Pt 1):1517-27.
[J Cell Biol. 1995]Annu Rev Cell Dev Biol. 2003; 19():423-43.
[Annu Rev Cell Dev Biol. 2003]Proc Natl Acad Sci U S A. 1993 Jun 15; 90(12):5519-23.
[Proc Natl Acad Sci U S A. 1993]Dev Biol. 1986 Oct; 117(2):456-87.
[Dev Biol. 1986]Nature. 2005 Jul 28; 436(7050):583-7.
[Nature. 2005]Mol Biol Cell. 2006 Nov; 17(11):4801-11.
[Mol Biol Cell. 2006]J Mol Biol. 2005 Feb 25; 346(3):677-87.
[J Mol Biol. 2005]Curr Biol. 2005 May 24; 15(10):935-41.
[Curr Biol. 2005]Trends Genet. 2006 Sep; 22(9):491-500.
[Trends Genet. 2006]Nat Genet. 2007 Nov; 39(11):1350-60.
[Nat Genet. 2007]Trends Genet. 2006 Sep; 22(9):491-500.
[Trends Genet. 2006]Cell. 2004 May 14; 117(4):527-39.
[Cell. 2004]Cell. 2004 May 14; 117(4):541-52.
[Cell. 2004]Curr Biol. 2005 May 24; 15(10):935-41.
[Curr Biol. 2005]Development. 2005 Apr; 132(8):1923-34.
[Development. 2005]Genetics. 1995 Jan; 139(1):171-88.
[Genetics. 1995]Mol Cell. 2000 Mar; 5(3):411-21.
[Mol Cell. 2000]Dev Biol. 1986 Oct; 117(2):456-87.
[Dev Biol. 1986]Genetics. 1992 Jan; 130(1):105-23.
[Genetics. 1992]Dev Biol. 1986 Oct; 117(2):456-87.
[Dev Biol. 1986]Genetics. 1995 Jan; 139(1):171-88.
[Genetics. 1995]Genetics. 1992 Jan; 130(1):105-23.
[Genetics. 1992]Dev Biol. 1986 Oct; 117(2):456-87.
[Dev Biol. 1986]Genetics. 1995 Jan; 139(1):171-88.
[Genetics. 1995]Neuron. 1995 Jan; 14(1):79-89.
[Neuron. 1995]Nature. 1999 Dec 16; 402(6763):804-9.
[Nature. 1999]Nature. 2003 Jan 16; 421(6920):268-72.
[Nature. 2003]Nat Genet. 2006 Mar; 38(3):363-8.
[Nat Genet. 2006]Curr Biol. 2005 May 24; 15(10):935-41.
[Curr Biol. 2005]Genome Biol. 2005; 6(2):R17.
[Genome Biol. 2005]Nature. 2005 Jul 28; 436(7050):583-7.
[Nature. 2005]Mol Biol Cell. 2006 Dec; 17(12):5053-62.
[Mol Biol Cell. 2006]Genes Dev. 2004 Jul 1; 18(13):1630-42.
[Genes Dev. 2004]Nature. 2005 Jul 28; 436(7050):583-7.
[Nature. 2005]Nat Cell Biol. 2004 Nov; 6(11):1109-13.
[Nat Cell Biol. 2004]Dev Biol. 1986 Oct; 117(2):456-87.
[Dev Biol. 1986]Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7157-62.
[Proc Natl Acad Sci U S A. 2007]Annu Rev Cell Dev Biol. 2003; 19():423-43.
[Annu Rev Cell Dev Biol. 2003]Traffic. 2003 Jul; 4(7):435-42.
[Traffic. 2003]Nat Cell Biol. 2004 Nov; 6(11):1109-13.
[Nat Cell Biol. 2004]Exp Cell Res. 2003 Apr 1; 284(2):251-63.
[Exp Cell Res. 2003]J Cell Biol. 2006 Sep 25; 174(7):1035-45.
[J Cell Biol. 2006]Nature. 2005 Jul 28; 436(7050):583-7.
[Nature. 2005]Annu Rev Physiol. 2007; 69():377-400.
[Annu Rev Physiol. 2007]Nature. 2005 Jul 28; 436(7050):583-7.
[Nature. 2005]Mol Biol Cell. 2007 May; 18(5):1554-69.
[Mol Biol Cell. 2007]Nat Genet. 2006 Mar; 38(3):363-8.
[Nat Genet. 2006]Proc Natl Acad Sci U S A. 2007 Apr 24; 104(17):7157-62.
[Proc Natl Acad Sci U S A. 2007]Exp Cell Res. 2003 Apr 1; 284(2):251-63.
[Exp Cell Res. 2003]Curr Biol. 2001 Oct 16; 11(20):1586-90.
[Curr Biol. 2001]Dev Cell. 2006 Jul; 11(1):9-19.
[Dev Cell. 2006]Nat Genet. 2007 Nov; 39(11):1350-60.
[Nat Genet. 2007]Nat Genet. 2005 Oct; 37(10):1135-40.
[Nat Genet. 2005]Nat Genet. 2005 May; 37(5):537-43.
[Nat Genet. 2005]Nat Genet. 2007 Nov; 39(11):1350-60.
[Nat Genet. 2007]Nat Genet. 2005 Oct; 37(10):1135-40.
[Nat Genet. 2005]J Biol Chem. 2000 Aug 4; 275(31):23852-60.
[J Biol Chem. 2000]Hum Mol Genet. 2003 Jul 1; 12(13):1591-608.
[Hum Mol Genet. 2003]Trends Genet. 2006 Sep; 22(9):491-500.
[Trends Genet. 2006]Exp Cell Res. 2003 Apr 1; 284(2):251-63.
[Exp Cell Res. 2003]Mol Biol Cell. 2007 May; 18(5):1554-69.
[Mol Biol Cell. 2007]J Neurosci. 2007 Jan 3; 27(1):15-26.
[J Neurosci. 2007]Proc Natl Acad Sci U S A. 2003 Jan 7; 100(1):289-94.
[Proc Natl Acad Sci U S A. 2003]J Cell Biol. 2005 Jul 4; 170(1):103-13.
[J Cell Biol. 2005]Cell. 2004 May 14; 117(4):541-52.
[Cell. 2004]Proc Natl Acad Sci U S A. 2005 Mar 8; 102(10):3703-7.
[Proc Natl Acad Sci U S A. 2005]Cell. 2004 May 14; 117(4):527-39.
[Cell. 2004]Dev Cell. 2006 Jul; 11(1):9-19.
[Dev Cell. 2006]Nat Genet. 2005 May; 37(5):537-43.
[Nat Genet. 2005]Nat Genet. 2007 Nov; 39(11):1350-60.
[Nat Genet. 2007]Mol Psychiatry. 2003 Jul; 8(7):685-94.
[Mol Psychiatry. 2003]Hum Mol Genet. 2005 Mar 1; 14(5):627-37.
[Hum Mol Genet. 2005]Mol Biol Cell. 2006 Dec; 17(12):5053-62.
[Mol Biol Cell. 2006]Genes Dev. 2004 Jul 1; 18(13):1630-42.
[Genes Dev. 2004]Genetics. 1995 Jan; 139(1):171-88.
[Genetics. 1995]Genes Dev. 2004 Jul 1; 18(13):1630-42.
[Genes Dev. 2004]Nature. 1999 Dec 16; 402(6763):804-9.
[Nature. 1999]Genetics. 1996 Jul; 143(3):1193-205.
[Genetics. 1996]Nature. 2003 Jan 16; 421(6920):268-72.
[Nature. 2003]Mol Biol Cell. 2006 Dec; 17(12):5053-62.
[Mol Biol Cell. 2006]Nat Cell Biol. 2004 Nov; 6(11):1109-13.
[Nat Cell Biol. 2004]Nature. 2006 Jan 19; 439(7074):326-30.
[Nature. 2006]Nat Genet. 2007 Nov; 39(11):1350-60.
[Nat Genet. 2007]